Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/288 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME11706459
PMID: | 11706459
LR: | 20061013
CED: | 20011114
DCO: | 20011210
Autoren: | Leslie M
Titel: | Knee osteoarthritis management therapies.
Quelle: | Pain management nursing : official journal of the American Society of Pain Management Nurses; VOL: 1 (2); p. 51-7 /200006/
PM: | Print
SU: | IM N
Sprache: | English
CY: | United States
JID: | 100890606
ISSN: | 1524-9042
Institution: | SCH Professional Corporation, Salem, OH, USA. MLHL@worldnet.att.net
DT: | Journal Article; Review
RN: | 37
Schlagwörter
CT: | ADJUVANTS, IMMUNOLOGIC/therapeutic use; ANALGESICS/therapeutic use; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL/therapeutic use; CHONDROITIN SULFATES/therapeutic use; EXERCISE; GLUCOSAMINE/therapeutic use; HUMANS; HYALURONIC ACID/therapeutic use; OSTEOARTHRITIS, KNEE/diagnosis; OSTEOARTHRITIS, KNEE/physiopathology; OSTEOARTHRITIS, KNEE/*therapy; PATIENT EDUCATION
CTG: | ADJUVANZIEN, IMMUNOLOGISCHE/therapeutische Anwendung; ANALGETIKA/therapeutische Anwendung; ANTIPHLOGISTIKA, NICHTSTEROIDALE/therapeutische Anwendung; CHONDROITINSULFATE/therapeutische Anwendung; TRAINING, KÖRPERLICHES; GLUCOSAMIN/therapeutische Anwendung; MENSCH; HYALURONSÄURE/therapeutische Anwendung; OSTEOARTHROSE, KNIE/Diagnose; OSTEOARTHROSE, KNIE/Pathophysiologie; OSTEOARTHROSE, KNIE/*Therapie; PATIENTENSCHULUNG
TE: | Adjuvants, Immunologic; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Glucosamine/3416-24-8; Hyaluronic Acid/9004-61-9; Chondroitin Sulfates/9007-28-7
CR: | 3416-24-8; 9004-61-9; 9007-28-7
AB: | Knee osteoarthritis (OA) is a common cause of pain and long-term disability in the elderly, and the incidence among middle-aged adults is considerable. Well-recognized risk factors associated with knee OA include age, women, being overweight or obese, major knee injury, and occupational overuse of the knee. Although loss of articular cartilage represents the pathological hallmark of knee OA, changes in subchondral bone and soft tissue are major features. Because knee OA is chronic and progressive, it is paramount that patients and health care professionals work together to manage symptoms, and to prevent and minimize deleterious consequences. Patient education, exercise, weight reduction, thermal modalities, assistive devices, medications, and neutraceuticals are important components of therapy. This article reviews common nonpharmacological and pharmacological therapies essential for the effective management of knee OA.

» Volltext »
» Fenster schließen »